£2.71m
−21%vs Dec 2024Active08337863Private limited companyLondon
AB BIOTECHNOLOGY LIMITED
Significant control: Irina Epshteyn (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Ab Biotechnology Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Ab Biotechnology Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AB BIOTECHNOLOGY LIMITED is an active private limited company (company number 08337863) incorporated on 20 December 2012, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 December 2025, showing net assets of £2.71m and cash of £1.58m, with 21 employees on average. Net assets fell 21% on the prior period (£3.45m).
Peer position · net assets
By net assets it sits in the top quarter of 143 comparable companies in London (median £100, upper quartile £10k).
02
Ownership and control
- Irina Epshteyn
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 20 December 201213 yrs ago
- Next accounts due
- 30 September 2027in 339 days
- Confirmation statement due
- 3 January 2027in 69 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- SmallCompanies Act thresholds
05
Financials
£1.58m
−64%vs Dec 2024Not reported
21
−5%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £2.71m | £1.58m | £1.26m | £1.67m | — | — | 21 |
| 31 December 2024 | £3.45m | £4.34m | £498k | £2.31m | — | — | 22 |
Current ratio1.86Current assets ÷ creditors within one year
Cash per employee£75kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,709,015 at 31 December 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 1.86
- Cash at bank of £50,000 or moreCash £1,578,316
- Incorporated five or more years agoIncorporated 20 December 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 339 days
- Confirmation statement duein 69 days
- Accounts period endNet assets £2.71m · small accounts
- Accounts period endNet assets £3.45m · small accounts
- Incorporated
08
Similar companies in London
- ATLANTIA UK LTDLondon · inc. Nov 2012
- PHARMACY WAREHOUSE LIMITEDLondon · inc. Nov 2012
- INNOVIT (UK) LTDLondon · inc. Aug 2012
- HOPE PHARMACEUTICALS, LTD.London · inc. Apr 2013
- PFLANCEN APOTHECARY LIMITEDLondon · inc. Jun 2012
- HERBAPHARMEDICA LIMITEDLondon · inc. Mar 2012
All companies incorporated on 20 December 2012 · in Dec 2012.
09
Reminders for AB BIOTECHNOLOGY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.